During immune escape, the presence of immune checkpoint molecules, such as programmed cell death 1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1), would hamper the tumor killing activity of CD8+ T cells [25, 26]. The gene discussed is CD8A; the disease is neoplasm.